Congenital heart defects -- occurrence, surgery and prognosis in a Danish County

Ester Garne1

  • 1Epidemiology, University of Southern Denmark, Odense, Denmark. Egarne@health.sdu.dk

Insights

Congenital heart disease (CHD) affects 7.9 per 1000 births, with high mortality in infants and children. While surgical outcomes improved, survival for severely ill newborns remains a challenge.

Area of Science:

  • Pediatric Cardiology
  • Public Health
  • Medical Malformations

Background:

  • Congenital heart disease (CHD) represents a significant global health concern.
  • Understanding population-based data on CHD prevalence, treatment, and outcomes is crucial for improving pediatric care.

Purpose of the Study:

  • To provide population-based data on the prevalence, surgical interventions, and mortality rates of congenital heart disease (CHD) in children up to five years of age.
  • To analyze trends in CHD outcomes over time.

Main Methods:

  • Utilized data from the EUROCAT Registry of Congenital Malformations in Funen County, Denmark, spanning 1986-1998.
  • Analyzed livebirth prevalence, intervention rates (surgery, catheter treatment), and mortality within the first five years of life.

Main Results:

  • A livebirth prevalence of 7.9 per 1000 births was observed for CHD.
  • Thirty-two percent of affected children underwent surgical or catheter treatment.
  • Eighteen percent of children died within five years, predominantly in the early years of life; 74% of deaths occurred without prior surgery.
  • A significant decline in mortality was noted in the later study period (1994-1998) compared to the earlier period (1986-1993).
  • Deaths within 28 days post-surgery significantly decreased.

Conclusions:

  • Infants and children with CHD experience high rates of mortality and morbidity, despite considerable improvements in surgical mortality.
  • Further improvements in survival may be possible for critically ill newborns awaiting surgery.
  • For newborns with multiple severe malformations, survival may not be feasible or advisable.
Abstract

Related Concept Videos

Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart tube by...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...